CY1115519T1 - Φαρμακευτικο παρασκευασμα που περιεχει λιπαση βακτηριακης προελευσης - Google Patents
Φαρμακευτικο παρασκευασμα που περιεχει λιπαση βακτηριακης προελευσηςInfo
- Publication number
- CY1115519T1 CY1115519T1 CY20141100699T CY141100699T CY1115519T1 CY 1115519 T1 CY1115519 T1 CY 1115519T1 CY 20141100699 T CY20141100699 T CY 20141100699T CY 141100699 T CY141100699 T CY 141100699T CY 1115519 T1 CY1115519 T1 CY 1115519T1
- Authority
- CY
- Cyprus
- Prior art keywords
- pharmaceutical preparation
- preparation containing
- bacterial origin
- containing bacterial
- origin lipase
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
Abstract
Το φαρμακευτικό παρασκεύασμα που προορίζεται για τη θεραπεία της παγκρεατικής ανεπάρκειας περιλαμβάνει μια ρευστή μορφή χορήγησης των ενζύμων.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/EP2009/000566 WO2010085975A1 (de) | 2009-01-29 | 2009-01-29 | Pharmazeutisches präparat enthaltend lipase bakteriellen ursprungs |
EP09776346.0A EP2391382B1 (de) | 2009-01-29 | 2009-01-29 | Pharmazeutisches präparat enthaltend lipase bakteriellen ursprungs |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1115519T1 true CY1115519T1 (el) | 2017-01-04 |
Family
ID=41091375
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20141100699T CY1115519T1 (el) | 2009-01-29 | 2014-09-02 | Φαρμακευτικο παρασκευασμα που περιεχει λιπαση βακτηριακης προελευσης |
Country Status (13)
Country | Link |
---|---|
US (2) | US20110293590A1 (el) |
EP (2) | EP2391382B1 (el) |
JP (1) | JP5970189B2 (el) |
CN (1) | CN102231988A (el) |
BR (1) | BRPI0922653B8 (el) |
CY (1) | CY1115519T1 (el) |
DK (1) | DK2391382T3 (el) |
ES (1) | ES2488407T3 (el) |
HR (1) | HRP20140715T1 (el) |
PL (1) | PL2391382T3 (el) |
PT (1) | PT2391382E (el) |
SI (1) | SI2391382T1 (el) |
WO (1) | WO2010085975A1 (el) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2165717A1 (de) | 2008-08-27 | 2010-03-24 | Nordmark Arzneimittel GmbH & Co.KG | Verfahren zur Verringerung der viralen und mikrobiellen Belastung feststoffhaltiger biologischer Extrakte |
PL2295039T5 (pl) | 2009-08-28 | 2023-02-27 | Nordmark Pharma Gmbh | Sposób wytwarzania granulek zawierających pankreatynę, w szczególności mikrogranulek zawierających pankreatynę, oraz wytworzone tym sposobem granulki zawierające pankreatynę |
PL2489349T3 (pl) | 2011-02-17 | 2014-09-30 | Nordmark Arzneimittel Gmbh & Co Kg | Granulki pankreatynowe, zwłaszcza mikrogranulki pankreatynowe, oraz sposób ich produkcji |
US8268305B1 (en) | 2011-09-23 | 2012-09-18 | Bio-Cat, Inc. | Method and compositions to reduce serum levels of triacylglycerides in human beings using a fungal lipase |
WO2013146529A1 (ja) * | 2012-03-28 | 2013-10-03 | 不二製油株式会社 | ランダムエステル交換油脂の製造方法 |
DE102015114857A1 (de) | 2015-09-04 | 2017-03-09 | Nordmark Arzneimittel Gmbh & Co. Kg | Getränk, enthaltend eine pharmazeutische Zusammensetzung |
DE102017104482A1 (de) | 2017-03-03 | 2018-09-06 | Nordmark Arzneimittel Gmbh & Co. Kg | Pharmazeutische Zusammensetzung umfassend Pankreatin und einen lipasehaltigen Überzug |
DE102017104501A1 (de) | 2017-03-03 | 2018-09-06 | Nordmark Arzneimittel Gmbh & Co. Kg | Pharmazeutische Zusammensetzung umfassend einen Träger und einen Überzug enthaltend wenigstens eine Lipase |
DE102017104480A1 (de) | 2017-03-03 | 2018-09-06 | Nordmark Arzneimittel Gmbh & Co. Kg | Wässrige Lösung von Burlulipase umfassend Kalziumionen |
DE102017104472A1 (de) * | 2017-03-03 | 2018-09-06 | Nordmark Arzneimittel Gmbh & Co. Kg | Schmelztablette enthaltend Burlulipase und daraus hergestellte pharmazeutische Zusammensetzung |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2189948A (en) | 1938-10-31 | 1940-02-13 | Griffith Laboratories | Sterilization of pancreatin |
DE2923279B1 (de) | 1979-06-08 | 1980-11-20 | Kali Chemie Pharma Gmbh | Verfahren zur Herstellung von Pankreatin-Pellets |
US5063160A (en) * | 1989-03-16 | 1991-11-05 | Olin Corporation | Identification, characterization, and method of production of a novel microbial lipase |
JP3025528B2 (ja) | 1989-11-24 | 2000-03-27 | ビオヘミー・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | パンクレアチン製剤 |
DK173590D0 (da) | 1990-06-06 | 1990-07-19 | Novo Nordisk As | Rekombinante terapeutiske lipaser |
DE59209604D1 (de) | 1991-07-01 | 1999-02-11 | Basf Ag | Verwendung von lipasen zur herstellung von arzneimitteln |
DE4227385A1 (de) | 1992-08-19 | 1994-02-24 | Kali Chemie Pharma Gmbh | Pankreatinmikropellets |
JPH08143469A (ja) * | 1994-11-14 | 1996-06-04 | Amano Pharmaceut Co Ltd | 膵外分泌機能不全症治療剤 |
DE19724845A1 (de) | 1996-08-28 | 1998-03-05 | Solvay Pharm Gmbh | Verwendung von komplexen Lipiden als stabilisierende Zusätze zu pharmazeutischen Zubereitungen von Verdauungsenzymgemischen |
US6270723B1 (en) | 1998-06-15 | 2001-08-07 | Bbi Bioseq, Inc. | Rapid cryobaric sterilization and vaccine preparation |
US20010046493A1 (en) * | 2000-02-24 | 2001-11-29 | Alex Margolin | Lipase-containing composition and methods of use thereof |
ATE272945T1 (de) * | 2000-04-06 | 2004-08-15 | Hannah Res Inst | Protein-stabilisierte emulsionen |
AT502588B1 (de) * | 2002-11-26 | 2010-05-15 | Brenner Franz | Papaya-mus |
EP1486415A1 (en) | 2003-06-12 | 2004-12-15 | SSP Technology A/S | Wind turbine blade and method of manufacturing a blade root |
US6908789B1 (en) | 2003-12-15 | 2005-06-21 | Intel Corporation | Method of making a microelectronic assembly |
PT1729797E (pt) * | 2004-03-22 | 2008-12-17 | Solvay Pharm Gmbh | Composições farmacêuticas orais de produtos contendo lipase, em particular de pancreatina, contendo tensioactivos |
JP4908420B2 (ja) * | 2004-10-14 | 2012-04-04 | アルタス ファーマシューティカルズ インコーポレイテッド | 膵機能不全を治療するための、リパーゼ、プロテアーゼおよびアミラーゼを含有する組成物 |
DE102004056340B4 (de) | 2004-11-22 | 2010-11-18 | Repower Systems Ag | Vorrichtung und Verfahren zur Montage und/oder Demontage eines Bauteils einer Windkraftanlage |
DE102005014868A1 (de) | 2005-03-30 | 2006-10-05 | Repower Systems Ag | Offshore-Windenergieanlage mit rutschfesten Füßen |
US11266607B2 (en) | 2005-08-15 | 2022-03-08 | AbbVie Pharmaceuticals GmbH | Process for the manufacture and use of pancreatin micropellet cores |
DE102006021982C5 (de) | 2006-05-10 | 2010-10-07 | Repower Systems Ag | Gestaffelt abschaltbarer Windpark |
US8246950B2 (en) * | 2007-02-20 | 2012-08-21 | Aptalis Pharma Limited | Stable digestive enzyme compositions |
DE102007014863A1 (de) | 2007-03-26 | 2008-10-02 | Repower Systems Ag | Verfahren zum Betreiben einer Windenergieanlage |
WO2008127567A1 (en) * | 2007-04-13 | 2008-10-23 | Beth Israel Deaconess Medical Center, Inc. | Novel nutritional food products for improved digestion and intestinal absorption |
DE102008012664A1 (de) | 2008-01-30 | 2009-08-06 | Repower Systems Ag | Windenergieanlage und ein Turm oder Turmsegment und eine Türzarge dafür |
EP2165717A1 (de) | 2008-08-27 | 2010-03-24 | Nordmark Arzneimittel GmbH & Co.KG | Verfahren zur Verringerung der viralen und mikrobiellen Belastung feststoffhaltiger biologischer Extrakte |
PL2295039T5 (pl) | 2009-08-28 | 2023-02-27 | Nordmark Pharma Gmbh | Sposób wytwarzania granulek zawierających pankreatynę, w szczególności mikrogranulek zawierających pankreatynę, oraz wytworzone tym sposobem granulki zawierające pankreatynę |
PL2489349T3 (pl) | 2011-02-17 | 2014-09-30 | Nordmark Arzneimittel Gmbh & Co Kg | Granulki pankreatynowe, zwłaszcza mikrogranulki pankreatynowe, oraz sposób ich produkcji |
-
2009
- 2009-01-29 SI SI200930988T patent/SI2391382T1/sl unknown
- 2009-01-29 EP EP09776346.0A patent/EP2391382B1/de active Active
- 2009-01-29 DK DK09776346.0T patent/DK2391382T3/da active
- 2009-01-29 CN CN2009801474407A patent/CN102231988A/zh active Pending
- 2009-01-29 PL PL09776346T patent/PL2391382T3/pl unknown
- 2009-01-29 PT PT97763460T patent/PT2391382E/pt unknown
- 2009-01-29 BR BRPI0922653A patent/BRPI0922653B8/pt active IP Right Grant
- 2009-01-29 WO PCT/EP2009/000566 patent/WO2010085975A1/de active Application Filing
- 2009-01-29 ES ES09776346.0T patent/ES2488407T3/es active Active
- 2009-01-29 US US13/146,653 patent/US20110293590A1/en not_active Abandoned
- 2009-01-29 JP JP2011546599A patent/JP5970189B2/ja active Active
- 2009-01-29 EP EP14170910.5A patent/EP2786761A1/de not_active Withdrawn
-
2014
- 2014-07-25 HR HRP20140715AT patent/HRP20140715T1/hr unknown
- 2014-09-02 CY CY20141100699T patent/CY1115519T1/el unknown
-
2016
- 2016-06-15 US US15/182,779 patent/US10596235B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
EP2786761A1 (de) | 2014-10-08 |
PT2391382E (pt) | 2014-08-22 |
BRPI0922653B8 (pt) | 2021-05-25 |
PL2391382T3 (pl) | 2014-11-28 |
US20160287679A1 (en) | 2016-10-06 |
BRPI0922653A2 (pt) | 2016-01-05 |
BRPI0922653B1 (pt) | 2021-04-13 |
WO2010085975A1 (de) | 2010-08-05 |
EP2391382A1 (de) | 2011-12-07 |
DK2391382T3 (da) | 2014-08-25 |
SI2391382T1 (sl) | 2014-10-30 |
JP2012516289A (ja) | 2012-07-19 |
US20110293590A1 (en) | 2011-12-01 |
CN102231988A (zh) | 2011-11-02 |
JP5970189B2 (ja) | 2016-08-17 |
HRP20140715T1 (hr) | 2014-09-26 |
ES2488407T3 (es) | 2014-08-27 |
US10596235B2 (en) | 2020-03-24 |
EP2391382B1 (de) | 2014-06-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1115519T1 (el) | Φαρμακευτικο παρασκευασμα που περιεχει λιπαση βακτηριακης προελευσης | |
BR112012015721A2 (pt) | modificação covalente de proteínas dirigida por ligante | |
EA201200559A1 (ru) | Способы назначения терапии пирфенидоном | |
BR112012018761A2 (pt) | estruturas para prevenir fixação de microorganismos | |
CR20140321A (es) | Sistema de administracion transdermica que contiene buprenofina | |
CL2015000812A1 (es) | Una capsula de bebida que comprende un cuerpo de capsula, una pared para inyeccion, una division, un medio para ruptura, una cantidad de un ingrediente de bebida, un soporte de sellado con una superficie de sellado; sistema de bebidas; y metodo de preparacion. | |
CO6640205A2 (es) | Microorganismos y metodos para la biosintesis de p-toluato y tereftalato | |
DK2464343T3 (da) | System til indgivelse af oftalmisk medicin indeholdende phospholipid og kolesterol | |
CL2015003580A1 (es) | Conjugados de suministro de polinucleotidos in vivo que tienen acoplamientos sensibles a enzima. | |
FI20085275A0 (fi) | Menetelmä biomassan käsittelemiseksi | |
MY200738A (en) | Pyrazole magl inhibitors | |
UA107476C2 (uk) | Фармацевтична субстанція на основі мітохондріально адресованих антиоксидантів | |
CL2012003523A1 (es) | Método para la preparación de una composición farmacéutica que contiene un portador de oxígeno termoestable; composicion farmaceutica que contiene un portador de oxigeno altamente purificado y termoestable. | |
BR112012029985A2 (pt) | métodos de determinação de rotatividade beta-amiloide no sangue. | |
MX347373B (es) | Soluciones anti-inflamatorias estables para inyección. | |
MX336787B (es) | Microorganismos deseñados geneticamente que comprenden 4-hidroxibenzoil-coa tioesterasas y metodos de uso de los mismos para producir acidos grasos libes y derivados de acidos grasos. | |
CL2011002649A1 (es) | Uso de un aerosol que comprende levofloxacina u ofloxacina para preparar un medicamento util para el tratamiento de una infeccion bacteriana pulmonar. | |
BR112012010760A2 (pt) | caldo de fermentação inseticida a partir de actinomicetos | |
BR112013016306A2 (pt) | preparação enzimática da fermentação de koji. | |
WO2010099510A3 (en) | Amino acid-based compounds, their methods of use, and methods of screening | |
MX349563B (es) | Formulacion farmaceutica de fenofibrato nanonizado. | |
CL2012003202A1 (es) | Metodo para tratar una infeccion gastrointestinal recurrente de clostridium difficile, que comprende la administracion de fidaxomicina y donde el sujeto ha sido sometido a un tratamiento previo para combatir dicha infeccion. | |
AR087586A1 (es) | Sistema enzimatico | |
EP2542560B8 (en) | Arylfluorophosphate inhibitors of intestinal apical membrane sodium/phosphate co-transport | |
MX2012001875A (es) | Proceso para la preparación de inhibidores de la catepsina s. |